NATCO Pharma Limited (BOM:524816)
817.00
-4.50 (-0.55%)
At close: Nov 20, 2026
NATCO Pharma Market Cap
NATCO Pharma has a market cap or net worth of 159.74 billion as of November 20, 2026. Its market cap has increased by 7.43% in one year.
Market Cap
159.74B
Enterprise Value
154.90B
Revenue
30.92B
Global Rank
n/a
Country Rank
n/a
PE Ratio
17.66
ChartMarket Cap Chart
Since March 31, 1999, NATCO Pharma's market cap has increased from 429.39M to 159.74B, an increase of 37,101.64%. That is a compound annual growth rate of 23.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 159.74B | -1.24% |
| Dec 31, 2025 | 161.75B | -34.91% |
| Dec 31, 2024 | 248.48B | 70.99% |
| Dec 29, 2023 | 145.32B | 41.73% |
| Dec 30, 2022 | 102.53B | -37.85% |
| Dec 31, 2021 | 164.98B | -5.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wockhardt | 355.21B |
| Piramal Pharma | 318.09B |
| Alembic Pharmaceuticals | 205.47B |
| Eris Lifesciences | 183.34B |
| Alivus Life Sciences | 178.02B |
| Cohance Lifesciences | 175.90B |
| NATCO Pharma | 161.05B |
| Sudeep Pharma | 136.43B |